People · Operator

Richard Birkmeyer, PhD

Named in public records as an officer, director or promoter · active 2019–2020 · Biotechnology

1
Companies
2
Filings
$28.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Tangen Biosciences, Inc.BiotechnologySeries A$28.4M$4.2M2019
Operator network

Richard Birkmeyer, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Dan Wagner · 4 companies · 1 sharedDan WagnerChristopher Benoit · 3 companies · 1 sharedChristopher BenoitChristopher McLeod · 3 companies · 1 sharedChristopher McLeodDaniel V. Wagner · 2 companies · 1 sharedDaniel V. WagnerJohn Davidson · 2 companies · 1 sharedJohn DavidsonAlan V. Levin · 1 companies · 1 sharedAlan V. LevinBrian Chirico · 1 companies · 1 sharedBrian ChiricoChristopher V. McLeod · 1 companies · 1 sharedChristopher V. Mc…John Nobile · 1 companies · 1 sharedJohn NobileJohn Richard Davidson · 1 companies · 1 sharedJohn Richard Davi…John Richard Nobile · 1 companies · 1 sharedJohn Richard Nobi…John V. Davidson · 1 companies · 1 sharedJohn V. DavidsonRichard C. Birkmeyer, PhD · 1 companies · 1 sharedRichard C. Birkme…Vance V. Kershner · 1 companies · 1 sharedVance V. KershnerTangen Biosciences, Inc. · $28.4M raisedTangen Biosciences, I…Richard Birkmeyer, PhDRP
Richard Birkmeyer, PhD Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Richard Birkmeyer, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Dan Wagner14
Christopher McLeod13
Christopher Benoit13
Daniel V. Wagner12
John Davidson12
Vance V. Kershner11
Christopher V. McLeod11
John V. Davidson11
Brian Chirico11
John Nobile11
John Richard Nobile11
John Richard Davidson11
Alan V. Levin11
Richard C. Birkmeyer, PhD11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.